secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aditxt, Inc. (ADTX)
CIK:        0001726711
Form:       8-K
Filed at:   2023-04-25T23:59:59+00:00
Accession:  0001213900-23-032484
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aditxt signs asset purchase agreement to acquire 50% ownership of Global Response Aid
--------------------------------------------------------------------------------

- Consideration for the acquisition includes $24.5 million ($14.5M loan forgiveness + $10M cash) and future royalty payments for 7 years.
- Aditxt will acquire 50% ownership in GRA, which holds exclusive worldwide license for Avigan 200mg (excluding Japan, China, Russia); other 50% owned by Agility.
- Closing conditions include financing, regulatory consents, release from Agility, securing third-party IP rights, and fairness opinion; termination possible before May 31, 2023.
- Nasdaq extended Panel Monitor until September 28, 2023 due to stock price falling below minimum bid price requirement.
- CEO and Chief Innovation Officer loaned $187,523.89 total; Company also obtained $1.06M business loan with $1.59M repayment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726711/000121390023032484/0001213900-23-032484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726711/000121390023032484/ea177341-8k_aditxt.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-032484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer